Upcoming Workshops
For All Cancers
For Breast Cancer
For Head and Neck Cancer
For Liver Cancer
For Mantle Cell Lymphoma
For Mesothelioma
Past workshops
For All Cancers
- Managing the Side Effects of Immunotherapy
Part II of New Trends in Immunotherapy - Understanding the Role of Immunotherapy in Treating Cancer
Part I of New Trends in Immunotherapy - Clinical Trials: How They Transform the Treatment of Cancer
- Update on Clinical Trials: How They Work
- New Perspectives in Clinical Trial Research
- Trends in Oncology and Treatment Planning: What You Need to Know
Part I of Life with Cancer: A Guide to Getting the Best Care
For Acute Lymphoblastic Leukemia
For Acute Myeloid Leukemia
For Basal Cell Cancer
For Bladder Cancer
For Bone Cancer
For Brain Cancer
For Breast Cancer
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- HER2-Positive Metastatic Breast Cancer: New Therapies
- Metastatic Breast Cancer: Treatment Updates
- Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
Part I of Your Guide to the Latest Cancer Research and Treatment - The Benefits of Clinical Trials for Triple Negative Breast Cancer
For Chronic Lymphocytic Leukemia
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Chronic Lymphocytic Leukemia: Current Treatment Perspectives
Part II of Living with Chronic Lymphocytic Leukemia - Update from the 2021 American Society of Hematology (ASH) Annual Meeting
For Chronic Myelogenous Leukemia
For Colorectal Cancer
For Cutaneous T-Cell Lymphoma
For Diffuse Large B-Cell Lymphoma
For Follicular Lymphoma
For Glioblastoma
For Head and Neck Cancer
For Hodgkin Lymphoma
For Leukemia
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Chronic Lymphocytic Leukemia: Current Treatment Perspectives
Part II of Living with Chronic Lymphocytic Leukemia - Update from the 2021 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
Part II of Equity. Every Patient. Every Day. Everywhere.
For Lung Cancer
For Lymphoma
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Diffuse Large B-Cell Lymphoma (DLBCL) Updates
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
Part II of Equity. Every Patient. Every Day. Everywhere.
For Mantle Cell Lymphoma
For Marginal Zone Lymphoma
For Melanoma
For Mesothelioma
For Metastatic Breast Cancer
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- HER2-Positive Metastatic Breast Cancer: New Therapies
- Metastatic Breast Cancer: Treatment Updates
- Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
Part I of Your Guide to the Latest Cancer Research and Treatment
For Multiple Myeloma
For Myelodysplastic Syndromes
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
Part II of Equity. Every Patient. Every Day. Everywhere.
For Myeloproliferative Neoplasms
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
Part II of Equity. Every Patient. Every Day. Everywhere.
For Non-Hodgkin Lymphoma
For Ovarian Cancer
For Pancreatic Cancer
For Peripheral T-Cell Lymphoma
For Prostate Cancer
For Sarcoma
For Skin Cancer
For Small Lymphocytic Lymphoma
For Squamous Cell Cancer
For Triple Negative Breast Cancer
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- HER2-Positive Metastatic Breast Cancer: New Therapies
- Metastatic Breast Cancer: Treatment Updates
- Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
Part I of Your Guide to the Latest Cancer Research and Treatment - The Benefits of Clinical Trials for Triple Negative Breast Cancer